Formation of anti-platelet factor 4/heparin antibodies after cardiac surgery: Influence of perioperative platelet activation, the inflammatory response, and histocompatibility leukocyte antigen status

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 6, 2008, Pages 1456-1463

  Paparella, Domenico ^a   Scrascia, Giuseppe ^a   Galeone, Antonella ^a   Coviello, Maria ^b   Cappabianca, Giangiuseppe ^a   Venneri, Maria Teresa ^b   Favoino, Biagio ^c   Quaranta, Michele ^b   de Luca Tupputi Schinosa, Luigi ^a   Warkentin, Theodore E ^d  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^c POLICLINICO   (Italy)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HISTOCOMPATIBILITY ANTIGEN; INTERLEUKIN 6; SEROTONIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART SURGERY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; THROMBOCYTE ACTIVATION;

AGED; ANTIBODIES; CARDIAC SURGICAL PROCEDURES; FEMALE; HEPARIN; HLA ANTIGENS; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET FACTOR 4;

EID: 57949101729     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.06.014     Document Type: Article

References (24)

1. Warkentin T.E., and Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 76 (2003) 2121-2131
2. Warkentin T.E., Sheppard J.A., Horsewood P., Simpson P.J., Moore J.C., and Kelton J.G. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96 (2000) 1703-1708
3. Warkentin T.E., and Heddle N.M. Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2 (2003) 148-157
4. Nepom G.T., and Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol 9 (1991) 493-525
5. Greinacher A., and Mueller-Eckhardt G. Heparin-associated thrombocytopenia: no association of immune response with HLA. Vox Sang 65 (1993) 151-153
6. Paparella D., Micelli M., Favoino B., D'Alò M., Fiore T., and de Luca Tupputi Schinosa L. Anti-heparin-platelet factor 4 antibodies after cardiopulmonary bypass: role of HLA expression. Haematologica 86 (2001) 326-327
7. Paparella D., Brister S.J., and Buchanan M.R. Coagulation disorder of cardiopulmonary bypass. A review. Intensive Care Med 30 (2004) 1873-1881
8. Parolari A., Camera M., Alamanni F., Naliato M., Polvani G.L., Agrifoglio M., et al. Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up. Ann Thorac Surg 84 (2007) 823-828
9. Horsewood P., Warkentin T.E., Hayward C.P.M., and Kelton J.G. The epitope specificity of heparin-induced thrombocytopenia. Br J Haematol 95 (1996) 161-167
10. In: Terasaki P.I., and Gjertson D.W. (Eds). HLA 1997 (1997), Tissue Typing Laboratory, Los Angeles, Calif
11. Tomasdottir H., Hjartarson H., Ricksten A., Wasslavik C., Bengtsson A., and Ricksten S.E. Tumor necrosis factor gene polymorphism is associated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery. Anesth Analg 97 (2003) 944-949
12. Visentin G.P., Malik M., Cyganiak K.A., and Aster R.H. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: platelet factor 4 complexes. J Lab Clin Med 128 (1996) 376-383
13. Pouplard C., May M.A., Iochmann S., Amiral J., Vissac A.M., Marchand M., et al. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia. Circulation 99 (1999) 2530-2536
14. Everett B.M., Yeh R., Foo S.Y., Criss D., Van Cott E.M., Laposata M., et al. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg 83 (2007) 592-597
15. Warkentin T.E., Hayward C.P., Boshkov L.K., Santos A.V., Sheppard J.A., Bode A.P., et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 84 (1994) 3691-3699
16. Rauova L., Zhai L., Kowalska M.A., Arepally G.M., Cines D.B., and Poncz M. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood 107 (2006) 2348-2353
17. Francis J.L., Palmer III G.J., Moroose R., and Drexler A. Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery. Ann Thorac Surg 75 (2003) 17-22
18. Williams R.T., Damaraju L.V., Mascelli M.A., Barnathan E.S., Califf R.M., Simoons M.L., et al. Anti-platelet factor 4 /heparin antibodies. An independent predictor of 30-day myocardial infarction after acute coronary syndrome. Circulation 107 (2003) 2307-2312
19. Bennett-Guerrero E., Slaughter T.F., White W., Welsby I.J., Greenberg C.S., El-Moalem H., and Ortel T.L. Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery. J Thorac Cardiovasc Surg 130 (2005) 1567-1572
20. Kress D.C., Aronson S., McDonald M.L., Malik M.I., Divgi A.B., Tector A.J., et al. Positive heparin-platelet factor 4 antibody complex and cardiac surgical outcomes. Ann Thorac Surg 83 (2007) 1737-1743
21. Paparella D., Yau T.M., and Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21 (2002) 232-244
22. Ferraccioli G., Peri F., Nervetti A., Ambanelli U., and Savi M. Toxicity due to remission induced drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens. J Rheumatol 13 (1986) 65-68
23. Rubin R.A., and Guay A.T. Susceptibility to subacute thyroiditis is genetically influenced: familial occurrence in identical twins. Thyroid 1 (1991) 157-161
24. Gao X., Nelson G.W., Karacki P., Martin M.P., Phair J., Kaslow R., et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 344 (2001) 1868-1875